BACKGROUND AND PURPOSE: The factor V Leiden mutation is associated with ischemic stroke in children but not in adults. Whether it is associated with ischemic stroke in young adults, however, is uncertain. METHODS: To address this issue, we performed a meta-analysis of 18 case-control studies of ischemic stroke in adults 50 years of age and younger published before June 2009. RESULTS: Across all studies, factor V Leiden was detected in 154 of 2045 cases (7.5%) and 217 of 5307 controls (4.1%), yielding a fixed-effect odds ratio of 2.00 (95% CI, 1.59-2.51). However, further analyses revealed substantial heterogeneity among these studies (P=0.005 for Q-test of heterogeneity). Hypothesizing that this heterogeneity could be related to differences among studies in case selection criteria, we stratified the meta-analysis into studies for which case samples were enriched or not enriched to include cases having an increased likelihood of prothrombotic genetic involvement ("selected" ischemic stroke studies, n=9) and those that recruited cases from consecutive neurology referrals or hospitalizations ("unselected" ischemic stroke studies, n=8). Among the 9 "selected" ischemic stroke studies, factor V Leiden was more strongly associated with stroke (OR, 2.73; 95% CI, 1.98-3.75), whereas among the 8 "unselected" ischemic stroke studies, the association between factor V Leiden and stroke was substantially weaker (OR, 1.40; 95% CI, 0.998-1.95). This difference was found to be statistically significant (P=0.003 for Woolf test for heterogeneity). CONCLUSIONS: We conclude that factor V Leiden is associated with ischemic stroke in young adults, particularly in patient populations in which there is an increased clinical suspicion of prothrombotic state.
BACKGROUND AND PURPOSE: The factor V Leiden mutation is associated with ischemic stroke in children but not in adults. Whether it is associated with ischemic stroke in young adults, however, is uncertain. METHODS: To address this issue, we performed a meta-analysis of 18 case-control studies of ischemic stroke in adults 50 years of age and younger published before June 2009. RESULTS: Across all studies, factor V Leiden was detected in 154 of 2045 cases (7.5%) and 217 of 5307 controls (4.1%), yielding a fixed-effect odds ratio of 2.00 (95% CI, 1.59-2.51). However, further analyses revealed substantial heterogeneity among these studies (P=0.005 for Q-test of heterogeneity). Hypothesizing that this heterogeneity could be related to differences among studies in case selection criteria, we stratified the meta-analysis into studies for which case samples were enriched or not enriched to include cases having an increased likelihood of prothrombotic genetic involvement ("selected" ischemic stroke studies, n=9) and those that recruited cases from consecutive neurology referrals or hospitalizations ("unselected" ischemic stroke studies, n=8). Among the 9 "selected" ischemic stroke studies, factor V Leiden was more strongly associated with stroke (OR, 2.73; 95% CI, 1.98-3.75), whereas among the 8 "unselected" ischemic stroke studies, the association between factor V Leiden and stroke was substantially weaker (OR, 1.40; 95% CI, 0.998-1.95). This difference was found to be statistically significant (P=0.003 for Woolf test for heterogeneity). CONCLUSIONS: We conclude that factor V Leiden is associated with ischemic stroke in young adults, particularly in patient populations in which there is an increased clinical suspicion of prothrombotic state.
Authors: Leon Bax; Noriaki Ikeda; Naohito Fukui; Yukari Yaju; Harukazu Tsuruta; Karel G M Moons Journal: Am J Epidemiol Date: 2008-12-08 Impact factor: 4.897
Authors: B Voetsch; B P Damasceno; E C Camargo; A Massaro; L A Bacheschi; M Scaff; J M Annichino-Bizzacchi; V R Arruda Journal: Thromb Haemost Date: 2000-02 Impact factor: 5.249
Authors: S Lopaciuk; K Bykowska; H Kwiecinski; A Mickielewicz; A Czlonkowska; T Mendel; A Kuczynska-Zardzewialy; D Szelagowska; J Windyga; W Schröder; F H Herrmann; H Jedrzejowska Journal: Clin Appl Thromb Hemost Date: 2001-10 Impact factor: 2.389
Authors: R Grossmann; U Geisen; G Merati; W Müllges; C M Schambeck; U Walter; S Schwender Journal: Blood Coagul Fibrinolysis Date: 2002-10 Impact factor: 1.276
Authors: Pasquale Madonna; Valentino de Stefano; Antonio Coppola; Ferdinando Cirillo; Anna Maria Cerbone; Giuseppe Orefice; Giovanni Di Minno Journal: Stroke Date: 2002-01 Impact factor: 7.914
Authors: Ali G Hamedani; John W Cole; Yuching Cheng; Mary J Sparks; Jeffrey R O'Connell; Oscar C Stine; Marcella A Wozniak; Barney J Stern; Braxton D Mitchell; Steven J Kittner Journal: J Stroke Cerebrovasc Dis Date: 2011-11-18 Impact factor: 2.136
Authors: James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson Journal: Stroke Date: 2014-10-28 Impact factor: 7.914
Authors: Noortje A M M Maaijwee; Loes C A Rutten-Jacobs; Pauline Schaapsmeerders; Ewoud J van Dijk; Frank-Erik de Leeuw Journal: Nat Rev Neurol Date: 2014-04-29 Impact factor: 42.937
Authors: Setareh S Omran; Michael P Lerario; Gino Gialdini; Alexander E Merkler; Antonio Moya; Monica L Chen; Hooman Kamel; Maria DeSancho; Babak B Navi Journal: J Stroke Cerebrovasc Dis Date: 2018-12-27 Impact factor: 2.136